Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Smartgene, Inc. v. Advanced Biological Lab, No. 13-1186 (Fed. Cir. Jan. 24, 2014)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 13-1186
Decided
January 24, 2014
Judge
Taranto, J.
Document
Nonprecedential Opinion
Length
10 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

SmartGene, Inc. brought this action against Advanced Biological Laboratories, SA , and ABL Patent Licensing Technologies, SARL (collectively, ABL), seeking a declara- tory judgment that it did not infringe two of ABL’s p a- tents, U.S. Patent Nos. 6,081,786 and 6,188,988, and that both patents were invalid. The district court granted summary judgment that all claims of both patents were ineligible for patent protection under 35 U.S.C. § 101. See SmartGene, Inc. v. Adv. Biological Labs., SA, 852 F. Supp. 2d 42, 62 (D.D.C.